White paper

A better way to LIMS: biology's modern solution

Legacy LIMS are overly rigid, costly, onerous to maintain, and built for chemistry, not modern biology. Outdated LIMS solutions cannot efficiently support the complexity of managing R&D for cell and gene therapies, antibody-drug conjugates, and RNA therapeutics. These modalities require advanced, built-for-biology software to process, analyze, and scale novel biomolecules into marketable products.
This whitepaper breaks down:
  • The challenges of using legacy LIMS in today’s world

  • The full lifecycle benefits of Benchling’s modern LIMS

  • Key features and use cases for Benchling’s modern LIMS solution

Companies using Benchling

View white paper

Join over 200,000 scientists using Benchling to power their biotech R&D

Helix Image